Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Yamashita, Akihiro ^a   Liu, Shiying ^a   Woltjen, Knut ^b,c   Thomas, Bradley ^a,h   Meng, Guoliang ^a   Hotta, Akitsu ^b,c,d,e   Takahashi, Kazutoshi ^b   Ellis, James ^e,f   Yamanaka, Shinya ^b,c,d,g   Rancourt, Derrick E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^h UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINE; CELL TRANSFORMATION; CHONDROGENESIS; CYTOLOGY; EMBRYONIC STEM CELL; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PLURIPOTENT STEM CELL; TISSUE ENGINEERING;

CARTILAGE; CELL DIFFERENTIATION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CHONDROCYTES; CHONDROGENESIS; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; TISSUE ENGINEERING;

EID: 84879635430     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01978     Document Type: Article

References (24)

1. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007). (Pubitemid 350138099)
2. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
3. Okita, K., Ichisaka, T.&Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317 (2007). (Pubitemid 47080336)
4. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106 (2008).
5. Nakagawa, M., Takizawa, N., Narita, M., Ichisaka, T. & Yamanaka, S. Promotion of direct reprogramming by transformation-deficient Myc. Proc. Natl. Acad. Sci. USA. 107, 14152-14157 (2010).
6. Guenther, M. G. et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7, 249-257 (2010).
7. Newman, A. M. & Cooper, J. B. Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7, 258-262 (2010).
8. Miura, K. et al. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 27, 743-745 (2009).
9. Yamashita, A., Nishikawa, S. & Rancourt, D. E. Identification of five developmental processes during chondrogenic differentiation of embryonic stem cells. PLoS One 5, e10998 (2010).
10. Medvedev, S. P. et al. Human Induced Pluripotent Stem Cells Derived from Fetal Neural Stem Cells Successfully Undergo Directed Differentiation into Cartilage. Stem Cells Dev. 20, 1099-1012 (2011).
11. Yamashita, A., Krawetz, R. & Rancourt, D. E. Loss of discordant cells during micro-mass differentiation of embryonic stem cells into the chondrocyte lineage. Cell Death Differ. 16, 278-286 (2009).
12. Hotta, A. et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat. Methods. 6, 370-376 (2009).
13. Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409-412 (2011).
14. Takahashi, Y. et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 6, 142-145 (2003). (Pubitemid 37221564)
15. Peng, S., Maihle, N. J. & Huang, Y. Pluripotency factors Lin28 and Oct4 identify a subpopulation of stem cell-like cells in ovarian cancer. Oncogene 29, 2153-2159 (2010).
16. Dang, C. V. et al. The c-Myc target gene network. Semin. Cancer Biol. 16, 253-264 (2006). (Pubitemid 44311039)
17. Viswanathan, S. R. et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 41, 843-848 (2009).
18. Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140-1144 (2009).
19. Iliopoulos, D., Hirsch, H. A. & Struhl, K. An epigenetic switch involving NFkappaB, Lin28, LET7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706 (2009).
20. Chang, T. C. et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc. Natl. Acad. Sci. USA. 106, 3384-9 (2009).
21. Dangi-Garimella, S. et al. Raf kinase inhibitory protein suppresses a metastasis signaling cascade involving LIN28 and let-7. EMBO J. 28, 347-58 (2009).
22. Feng, Q. et al.Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28, 704-712 (2010).
23. Hu, B. Y. et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl. Acad. Sci. USA. 107, 4335-4340 (2010).
24. Kajiwara, M. et al. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA. 109, 12538-12543 (2012).